Novo Nordisk Impresses with Survey – Wegovy Also Improves Mental Health
Reading Time: 2 minutes
Novo Nordisk (NYSE: NVO) published results from a U.S. survey on Tuesday, highlighting the potential of its blockbuster Wegovy beyond mere weight reduction. In a survey of 550 patients, it was found that the treatment not only improved weight but also significantly enhanced the mental well-being and lifestyle of the participants. Particularly noteworthy is the reduction of what is known as "Food Noise" – intrusive, unwanted thoughts about food. While 62 percent of respondents reported thinking about food constantly before starting the therapy,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
